Pharmacology Flashcards
(115 cards)
What is the stepwise approach for asthma pharmacological management according to the Australian guidelines?
Step 1 - intermittent asthma (as-needed short-acting beta2 agonist (SABA))
Step 2 - mild persistent asthma (regular low-dose ICS)
Step 3 - moderate persistent asthma (low-dose ICS and additional therapy)
Step 4 - moderate to severe persistent asthma (medium-dose ICS and additional therapy)
Step 5 - severe persistent asthma (high-dose ICS and additional therapy).
When is it appropriate to add a long-acting beta2 agonist (LABA) to inhaled corticosteroid (ICS) therapy for asthma?
According to the Australian guidelines, a LABA may be added to ICS therapy for asthma when the patient has persistent asthma symptoms despite treatment with low-dose ICS, or when the patient has moderate to severe asthma.
What is the recommended treatment for acute asthma exacerbations?
The recommended treatment for acute asthma exacerbations includes a short-acting beta2 agonist (SABA) delivered via inhaler or nebulizer, along with oral or intravenous corticosteroids. Oxygen therapy may also be necessary for severe exacerbations.
How often should asthma control be assessed in patients receiving pharmacological therapy?
According to the Australian guidelines, asthma control should be assessed at every visit for patients receiving pharmacological therapy for asthma. This includes monitoring symptoms, medication use, lung function, and exacerbation history.
What are the potential side effects of inhaled corticosteroids (ICS) used for asthma management? How can they be minimized?
The potential side effects of ICS used for asthma management include hoarseness, oral thrush, and dysphonia. These side effects can be minimized by using a spacer and rinsing the mouth after inhalation.
What are the potential side effects of beta2 agonists used for asthma?
The most common adverse effects of beta2 agonists used for asthma include tremors, tachycardia, palpitations, headache, hyperactivity, and hypokalemia.
What is the first-line pharmacological treatment for primary hypertension?
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin receptor blockers (ARBs)
Calcium channel blockers (CCBs)
Thiazide diuretics
When would beta blockers be indicated for hypertension?
These medications may be preferred for patients with a history of myocardial infarction, heart failure with reduced ejection fraction, or atrial fibrillation. However, they should be avoided or used with caution in patients with asthma or chronic obstructive pulmonary disease.
What considerations are there for the use of calcium channel blockers for hypertension?
These medications may be preferred for patients with coronary artery disease, angina, or peripheral artery disease. However, they should be avoided or used with caution in patients with heart failure.
What considerations are there for the use of ACEi/ARBs for hypertension?
These medications may be preferred for patients with diabetes or chronic kidney disease, as they have shown to provide renal protection. However, caution should be taken in patients with bilateral renal artery stenosis or a history of angioedema
Which antihypertensives are recommended for diabetic patients?
ACEIs or ARBs (protective against diabetic nephropathy)
Difference between dihydropyridine and non-dihydropyridine CCBs. Mention examples of each.
Dihydropyridine CCBs primarily work by relaxing the smooth muscle cells in the walls of blood vessels, leading to vasodilation and a decrease in blood pressure. They have minimal effects on cardiac muscle cells and the electrical conduction system of the heart. Some examples of dihydropyridine CCBs include amlodipine, nifedipine, and felodipine.
Non-dihydropyridine CCBs have a greater effect on the heart and its electrical conduction system, and are therefore useful in treating certain arrhythmias such as atrial fibrillation. They also have some effect on blood vessels, but not as much as dihydropyridine CCBs. Some examples of non-dihydropyridine CCBs include verapamil and diltiazem.
Indications for nitrates
Angina pectoris
- Short-acting nitrates such as sublingual nitroglycerin, isosorbide dinitrate, or nitroglycerin spray for treatment of acute attacks
- Long-acting nitrates such as isosorbide mononitrate can be taken regularly (2–3 times daily) for anginal prophylaxis: unlike some other nitrates, isosorbide mononitrate does not undergo first-pass metabolism by the liver and thus has ∼100% bioavailability.
What are the effects of aspirin based on dosage?
Low dose (below 300 mg/day): inhibition of platelet aggregation, cardiovascular prevention
Intermediate dose (300-2400 mg/day): antipyretic and analgesic effect
High dose (2400-4000 mg/day): anti-inflammatory effect
Adverse effects of aspirin
Gastrointestinal effects: Aspirin can irritate the lining of the stomach and cause ulcers and bleeding in the stomach and intestines.
Bleeding: Aspirin can interfere with blood clotting and increase the risk of bleeding, especially in people who are taking other medications that also affect blood clotting.
Allergic reactions: Some people may be allergic to aspirin and experience symptoms such as hives, swelling, and difficulty breathing.
Reye’s syndrome: Aspirin use in children and teenagers with viral illnesses such as the flu or chickenpox has been linked to Reye’s syndrome, a rare but serious condition that can cause liver and brain damage.
Kidney damage: Long-term use of high doses of aspirin can damage the kidneys.
When would clopidogrel be indicated?
Clopidogrel is indicated for the prevention of blood clots, particularly in people with a history of heart attack, stroke, peripheral arterial disease, or acute coronary syndrome. It is also used in combination with aspirin to prevent blood clots in people with acute coronary syndrome or those undergoing percutaneous coronary intervention (PCI).
Mention examples of parenteral and oral anticoagulants.
Examples of parenteral anticoagulants include:
- Heparin
- Enoxaparin
Examples of oral anticoagulants include:
- Warfarin
- Dabigatran
- Rivaroxaban
- Apixaban
What is the therapeutic range for activated partial thromboplastin time (aPTT) when using unfractionated heparin (UFH)?
The therapeutic range for aPTT when using UFH is typically 1.5 to 2.5 times the control value. However, the exact target range may vary depending on the clinical situation and the patient’s individual characteristics.
Which is the preferred agent for patients with severe renal impairment?
LMWH or UFH
While it is true that unfractionated heparin (UFH) is primarily cleared hepatically, both UFH and low molecular weight heparin (LMWH) can be used in patients with renal insufficiency. However, LMWH is generally preferred over UFH because it has a more predictable pharmacokinetic profile, a lower risk of bleeding complications, and does not require routine laboratory monitoring.
UFH may be preferred in certain situations such as patients with severe renal impairment or those requiring rapid anticoagulation reversal.
When would LMWH be indicated over UFH?
- DVT prophylaxis, outpatient care (longer half-life → fewer injections)
- Generally preferred to UFH (fewer side effects, easier handling) as long as there are no contraindication (preferred in pregnancy)
When would UFH be indicated over LMWH?
- Emergencies (more easily titrated, available as IV infusion)
- For patients with advanced renal failure (e.g., in patients with severe renal insufficiency (CrCl < 30mL/min) or the elderly)
- Pregnancies (does not cross placental barrier)
Advantages and disadvantages of UFH.
Advantages:
Short half-life, allowing for rapid reversal if necessary
Can be used in patients with renal failure or in situations where renal function is uncertain, as it is not primarily cleared by the kidneys
Disadvantages:
Requires frequent monitoring of activated partial thromboplastin time (aPTT) to adjust dose
Can cause bleeding, heparin-induced thrombocytopenia (HIT), and osteoporosis with long-term use
Requires continuous IV infusion or frequent subcutaneous injections
Advantages and disadvantages of LMWH.
Advantages:
More predictable anticoagulant effect, allowing for fixed dosing without routine monitoring
Lower risk of bleeding and HIT compared to UFH
Longer half-life, allowing for once or twice daily dosing
Does not require continuous IV infusion
Disadvantages:
Not easily reversible, with no specific antidote available
More expensive than UFH
May accumulate in patients with renal impairment and require dose adjustment
Indications of UFH
Atrial fibrillation
DVT, acute arterial thrombosis, pulmonary embolism
Acute coronary syndrome, myocardial infarction
Mechanical heart valve replacement
VTE prophylaxis for patients with hemodialysis, heart-lung machine, etc.